Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie A Crews

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
British Journal of Pharmacology|August 14, 2014
Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disordersWolf Wrasidlo, Leslie A Crews, Igor F Tsigelny, et al.
Cell Stem Cell|January 21, 2021
Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruptionPhoebe K Mondala, Ashni A Vora, Tianyuan Zhou, et al.
International Journal of Molecular Sciences|October 14, 2023
The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple MyelomaNatalia Platonova, Elisa Lazzari, Michela Colombo, et al.
Oncotarget|July 28, 2016
Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow nicheMichela Colombo, Serena Galletti, Gaetano Bulfamante, et al.
Cornea|April 6, 2012
Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease managementBenjamin D Sullivan, Leslie A Crews, Barış Sönmez, et al.
Nature Communications|December 6, 2017
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myelomaElisa Lazzari, Phoebe K Mondala, Nathaniel Delos Santos, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
The Proteostasis Network is a Therapeutic Target in Acute Myeloid LeukemiaKentson Lam, Yoon Joon Kim, Carlo M Ong, et al.
Cell Stem Cell|August 30, 2016
RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AMLLeslie A Crews, Larisa Balaian, Nathaniel P Delos Santos, et al.
Blood|October 20, 2025
The Proteostasis Network is a Therapeutic Target in Acute Myeloid LeukemiaKentson Lam, Yoon Joon Kim, Evelyn Li-Ting Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2013
ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemiaQingfei Jiang, Leslie A Crews, Christian L Barrett, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
British Journal of Pharmacology|August 14, 2014
Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disordersWolf Wrasidlo, Leslie A Crews, Igor F Tsigelny, et al.
Cell Stem Cell|January 21, 2021
Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruptionPhoebe K Mondala, Ashni A Vora, Tianyuan Zhou, et al.
International Journal of Molecular Sciences|October 14, 2023
The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple MyelomaNatalia Platonova, Elisa Lazzari, Michela Colombo, et al.
Oncotarget|July 28, 2016
Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow nicheMichela Colombo, Serena Galletti, Gaetano Bulfamante, et al.
Cornea|April 6, 2012
Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease managementBenjamin D Sullivan, Leslie A Crews, Barış Sönmez, et al.
Nature Communications|December 6, 2017
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myelomaElisa Lazzari, Phoebe K Mondala, Nathaniel Delos Santos, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
The Proteostasis Network is a Therapeutic Target in Acute Myeloid LeukemiaKentson Lam, Yoon Joon Kim, Carlo M Ong, et al.
Cell Stem Cell|August 30, 2016
RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AMLLeslie A Crews, Larisa Balaian, Nathaniel P Delos Santos, et al.
Blood|October 20, 2025
The Proteostasis Network is a Therapeutic Target in Acute Myeloid LeukemiaKentson Lam, Yoon Joon Kim, Evelyn Li-Ting Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2013
ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemiaQingfei Jiang, Leslie A Crews, Christian L Barrett, et al.
Pageof 3